James Berenson
- Molecular Biology
- Oncology top 10%
- Hematology top 5%
- Immunology
- Genetics top 10%
- Co-authors
- Robert VescioAlan LichtensteinA. FleishmanJeremy M. G. TaylorMatthew B. RettigJohn C. ReedYiping TuJudith Weisz
- Topics
- Multiple Myeloma Research and Treatments (14 papers)Cancer Treatment and Pharmacology (5 papers)Bone health and treatments (4 papers)
- Cited by
- HematologyGeneticsOncology
- Partner nations
- United StatesChinaGreece
In The Last Decade
James Berenson
23 papers receiving 550 citations
Peers
Comparison fields: 5 of 64
- Molecular Biology 310
- Oncology 250
- Hematology 207
- Immunology 122
- Genetics 100
Countries citing papers authored by James Berenson
This map shows the geographic impact of James Berenson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James Berenson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James Berenson more than expected).
Fields of papers citing papers by James Berenson
This network shows the impact of papers produced by James Berenson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James Berenson. The network helps show where James Berenson may publish in the future.
Co-authorship network of co-authors of James Berenson
This figure shows the co-authorship network connecting the top 25 collaborators of James Berenson. A scholar is included among the top collaborators of James Berenson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James Berenson. James Berenson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 1 | |
| 3 | 4 | |
| 4 | 4 | |
| 5 | 1 | |
| 6 | 27 | |
| 7 | 20 | |
| 8 | 1 | |
| 9 | 2 | |
| 10 | Phase II trial of zoledronate versus pamidronate in multiple myeloma and breast carcinoma patients with osteolytic lesions | 1 |
| 11 | 7 | |
| 12 | 45 | |
| 13 | 11 | |
| 14 | 71 | |
| 15 | Phase I-II study of busulfan and cyclophosphamide conditioning for transplantation in advanced multiple myeloma. | 17 |
| 16 | Threshold dose of autologous CD34-positive peripheral blood progenitor cells required for engraftment after myeloablative treatment for multiple myeloma | 4 |
| 17 | Resistance of human ovarian cancer cells to tumor necrosis factor and lymphokine-activated killer cells: correlation with expression of HER2/neu oncogenes. | 53 |
| 18 | BCL-X expression in multiple myeloma: possible indicator of chemoresistance. | 201 |
| 19 | Oncogenes in multiple myeloma: point mutation of N-ras. | 38 |
| 20 | Clonal rearrangement of the beta-T cell receptor gene in multiple myeloma. | 9 |
About James Berenson
James Berenson is a scholar working on Hematology, Oncology and Transplantation, having authored 23 papers that have together received 564 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (14 papers), Cancer Treatment and Pharmacology (5 papers) and Bone health and treatments (4 papers). The work is most often cited by research in Hematology (207 citations), Genetics (100 citations) and Oncology (250 citations). James Berenson has collaborated with scholars based in United States, China and Greece. Frequent co-authors include Robert Vescio, Alan Lichtenstein, A. Fleishman, Jeremy M. G. Taylor, Matthew B. Rettig, John C. Reed, Yiping Tu, Judith Weisz, Stanisław Krajewski and Fei Xu. Their work appears in journals such as Journal of Clinical Oncology, Blood and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.